Zevra Therapeutics Stock Zoomed: Why the 21% Jump Happened
Zevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Planning for retirement now can significantly enhance your financial security. Learn the reasons to prioritize your retirement planning today.
27,829 articlesZevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Two powerhouse ideas could propel your portfolio toward the next decade: a campus-wide AI infrastructure leader and a...
January payrolls rose 130,000 with the jobless rate at 4.3%, while revisions to prior months add uncertainty as trade...
Investors debating the better crypto buy: bitcoin face a choice between owning Bitcoin outright or stepping into a Bi...
Willdan stock skyrocketing has investors buzzing as one large fund sold about $7.74 million worth of shares. This art...
Oklo stock surged as investors weighed its plans for advanced reactors against the fast-moving AI data-center boom. T...
As Magnachip heads into 2025 earnings season, investors want clarity on revenue growth, margins, and capital allocati...
Global markets tumbled as President Trump signaled a major escalation with Iran, sending oil higher and volatility so...
FUTY has delivered 64% returns over five years while charging just 0.084% in fees, as the utility sector blends stead...
MIT economist and public thinker Daron Acemoglu argues AI's productivity gains will be modest in the near term, while...
Tech shares rebound as AI demand supports earnings. This report highlights the best tech stocks right now, detailing ...
When an institutional investor takes a large position in a biotech stock, it can signal potential credibility or risk...